CClinicalTrials.gg
CompletedNCT03763279Updated Sep 16, 2019

Effect of Barbed Suture and Triclosan-coated Monofilament in Emergency Surgery

A Phase 3 interventional study of Triclosan-coated barbed suture and Triclosan-coated monofilament suture in Surgical Site Infection, sponsored by Hospital General Universitario Elche. Completed at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-09-16.

Sponsored by Hospital General Universitario Elche · Phase 3, Interventional, and Prevention

Phase
Phase 3
Study type
Interventional
Enrollment
150
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Patients will be randomized 3 groups:

Group 1: Abdominal fascial closure will be performed with Triclosan-coated barbed Polydioxanone suture

Group 2:Abdominal fascial closure will be performed with Triclosan-coated monofilament Polydioxanone suture

Group 3: Abdominal fascial closure will be performed with monofilament Polydioxanone suture

Incisional surgical.site infection and evisceration will be recorded.

Read the detailed description

Patients will be randomized 3 groups:

Group 1: Abdominal fascial closure will be performed with Triclosan-coated barbed Polydioxanone suture (Stratafix Symmetric, J\&J), caliber 1, 48mm-cylindric needle.

Group 2:Abdominal fascial closure will be performed with Triclosan-coated Polydioxanone loop suture (PDS plus looc, J\&J), caliber 1, 48mm-cylindric needle.

Group 3: Abdominal fascial closure will be performed with Polydioxanone loop suture (PDS plus looc, J\&J), caliber 1, 48mm-cylindric needle.

Incisional surgical.site infection and evisceration will be recorded.

02

Conditions studied

  • Surgical Site Infection
03

In context

Surgical Wound Infection

670 studies on the registry are indexed under Surgical Wound Infection; 141 are open to participants now.

This study's enrollment of 150 is below the median of 200 across 514 interventional studies indexed under Surgical Wound Infection.

Browse Surgical Wound Infection studies →

Lead sponsor

Hospital General Universitario Elche is the lead sponsor of 43 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Contaminated and Dirty surgery
  • Emergency surgery performed by midline laparotomic approach
  • The following diagnosis will be included:

    • Anastomotic leak of previous digestive surgery (colon, small bowel or gastric surgery)
    • Colonic or bowel perforations
    • Appendicitis with purulent of fecal peritonitis, undergoing midline laparotomy
    • Perforation of gastric or duodenal ulcer
    • Intestinal ischemia requiring bowel resection

Exclusion criteria

Exclusion Criteria:

  • Emergency surgery undergoing laparoscopic approach
  • Appendicitis operated by McBurney incision
  • Intestinal isquemia without requiring bowel resection
05

Study design

Phase
Phase 3
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
150 participants (actual)

Study arms

  • Experimental
    Triclosan-coated barbed suture

    Abdominal wall closure will be performed using a Triclosan-coated Polydioxanone barbed suture

    Combination Product: Triclosan-coated barbed suture

  • Experimental
    Triclosan-coated monofilament suture

    Abdominal wall closure will be performed using a Triclosan-coated Polydioxanone monofilament suture

    Combination Product: Triclosan-coated monofilament suture

  • Sham comparator
    Monofilament suture

    Abdominal wall closure will be performed using a monofilament suture

    Device: Monofilament suture

Interventions

  • Combination productTriclosan-coated barbed suture

    Use of Triclosan-coated Polydioxanone barbed suture

  • Combination productTriclosan-coated monofilament suture

    Use of Triclosan-coated Polydioxanone monofilament suture

  • DeviceMonofilament suture

    Use of Polydioxanone monofilament suture

06

What researchers measure

Primary outcomes

  1. Rate of incisional surgical-site infection

    Diagnosis of incisional surgical-site infection during the postoperative course

    Time frame: 30 days postoperatively

Secondary outcomes

  1. Rate of Evisceration

    Diagnosis of evisceration during the postoperative course, which will be assessed by physical examination

    Time frame: 30 days postoperatively

07

Study locations

1 site
  • General Hospital Elche
    Elche, Alicante 03203, Spain
08

References and documents

Publications

  • Ruiz-Tovar J, Llavero C, Jimenez-Fuertes M, Duran M, Perez-Lopez M, Garcia-Marin A. Incisional Surgical Site Infection after Abdominal Fascial Closure with Triclosan-Coated Barbed Suture vs Triclosan-Coated Polydioxanone Loop Suture vs Polydioxanone Loop Suture in Emergent Abdominal Surgery: A Randomized Clinical Trial. J Am Coll Surg. 2020 May;230(5):766-774. doi: 10.1016/j.jamcollsurg.2020.02.031. Epub 2020 Feb 27. PubMed 32113031 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 16, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03763279
Lead sponsor
Hospital General Universitario Elche
Responsible party
Jaime Ruiz-Tovar, MD, PhD (Professor of Surgery, Hospital General Universitario Elche) — Principal investigator
First posted
Dec 4, 2018
Start date
Nov 30, 2018
Primary completion
Mar 31, 2019
Completion
Mar 31, 2019
Last update
Sep 16, 2019

Study contacts

Andres Garcia-Marin
study director · Hospital de San Juan

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion